[Antiblastic chemotherapy and its oral manifestations (III)].
D000380:Agranulocytosis / Q000517:prevention & control; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001424:Bacterial Infections / Q000517:prevention & control; D002180:Candidiasis, Oral / Q000517:prevention & control; D006801:Humans; D009059:Mouth Diseases / Q000139:chemically induced* / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents
Chemioterapia antiblastica e sue manifestazioni orali (III).